Literature DB >> 17973975

New algorithm for the treatment of gastro-oesophageal reflux disease.

G N Tytgat1, K McColl, J Tack, G Holtmann, R H Hunt, P Malfertheiner, A P S Hungin, H K Batchelor.   

Abstract

BACKGROUND: Gastro-oesophageal reflux disease (GERD) is associated with a variety of typical and atypical symptoms. Patients often present in the first instance to a pharmacist or primary care physician and are subsequently referred to secondary care if initial management fails. Guidelines usually do not provide a clear guidance for all healthcare professionals with whom the patient may consult. AIM: To update a 2002-treatment algorithm for GERD, making it more applicable to pharmacists as well as doctors.
METHODS: A panel of international experts met to discuss the principles and practice of treating GERD.
RESULTS: The updated algorithm for the management of GERD can be followed by pharmacists, for over-the-counter medications, primary care physicians, or secondary care gastroenterologists. The algorithm emphasizes the importance of life style changes to help control the triggers for heartburn and adjuvant therapies for rapid and adequate symptom relief. Proton pump inhibitors will remain a prominent treatment for GERD; however, the use of antacids and alginate-antacids (either alone or in combination with acid suppressants) is likely to increase.
CONCLUSION: The newly developed algorithm takes into account latest clinical practice experience, offering healthcare professionals clear and effective treatment options for the management of GERD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17973975     DOI: 10.1111/j.1365-2036.2007.03565.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  19 in total

1.  Prevalence of gastro-oesophageal reflux disease with upper gastrointestinal symptoms without heartburn and regurgitation.

Authors:  Nimish Vakil; Börje Wernersson; Lis Ohlsson; John Dent
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

2.  A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes.

Authors:  Mehran Anvari; Christopher Allen; John Marshall; David Armstrong; Ron Goeree; Wendy Ungar; Charles Goldsmith
Journal:  Surg Endosc       Date:  2011-04-22       Impact factor: 4.584

Review 3.  Gastroesophageal reflux and altered motility in lung transplant rejection.

Authors:  J M Castor; R K Wood; A J Muir; S M Palmer; R A Shimpi
Journal:  Neurogastroenterol Motil       Date:  2010-05-26       Impact factor: 3.598

Review 4.  Ambulatory reflux monitoring in GERD--which test should be performed and should therapy be stopped?

Authors:  Andrew J Gawron; John E Pandolfino
Journal:  Curr Gastroenterol Rep       Date:  2013-04

Review 5.  Management of refractory typical GERD symptoms.

Authors:  Emidio Scarpellini; Daphne Ang; Ans Pauwels; Adriano De Santis; Tim Vanuytsel; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-14       Impact factor: 46.802

Review 6.  Gastroesophageal reflux disease in children and adolescents: when and how to treat.

Authors:  Matthew W Carroll; Kevan Jacobson
Journal:  Paediatr Drugs       Date:  2012-04-01       Impact factor: 3.022

7.  Acid peptic diseases: pharmacological approach to treatment.

Authors:  Alex Mejia; Walter K Kraft
Journal:  Expert Rev Clin Pharmacol       Date:  2009-05       Impact factor: 5.045

8.  Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX.

Authors:  Guy-Bernard Cadière; Nathalie Van Sante; Jaime E Graves; Anna K Gawlicka; Amin Rajan
Journal:  Surg Endosc       Date:  2009-03-14       Impact factor: 4.584

Review 9.  Body weight, lifestyle, dietary habits and gastroesophageal reflux disease.

Authors:  Davide Festi; Eleonora Scaioli; Fabio Baldi; Amanda Vestito; Francesca Pasqui; Anna Rita Di Biase; Antonio Colecchia
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

10.  Gastroesophageal reflux disease: medical or surgical treatment?

Authors:  Theodore Liakakos; George Karamanolis; Paul Patapis; Evangelos P Misiakos
Journal:  Gastroenterol Res Pract       Date:  2009-12-31       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.